Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Japan

Sawai, Towa Announce Strong Results

August 2006 | Market Trend Analysis

Leading Japanese generic manufacturers Sawai and Towa have announced solid results for the first quarter of the 2006-07 financial year. The two companies, which formed a product development alliance with fellow generics maker Nichi-iko in February 2006, have reported strong orders for their products so far this

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
New Medical Fees Clarify Hospital Sector Policy

Companies / Japan According to a new report by risk ratings agency Fitch, market watchers have not appreciated the true impact of recent revisions to Japan's medical fees system. This year's cuts were the deepest ever,...
August 2006
Merck & Co Tests Januvia, Amid 'Drug Lag' Concerns

Companies / Japan US drug major Merck & Co has begun trials in Japan for its novel antibiabetic sitagliptin, branded in global markets as Januvia. The orally administered drug, a first-in-class dipeptidyl peptidase-IV...
August 2006
Multinationals Eye Japan's Cancer Market

Companies / Japan According to industry experts, prospects for a significant expansion of Japan's US$3.2bn cancer market are set to improve significantly. New product launches by foreign-owned companies, and a health...
August 2006
MNC Products Key To Japanese Firms' Success?

Companies / Japan Results for the 2005-06 financial year released by Japanese companies illustrate that products developed by foreign firms are playing a key role in the fortunes of the indigenous industry. At a time...
May 2006
Chugai Files Avastin, Reports Profit Drop

Companies / Japan Chugai, the Japanese affiliate of Swiss pharmaceutical major Roche, has filed a submission for colorectal cancer drug Avastin (bevacizumab) with the health ministry. A new ministry committee is expected...
April 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS